Nanovibronix, Inc. (NASDAQ:FEED) Short Interest Update

Nanovibronix, Inc. (NASDAQ:FEED) was the target of a large decline in short interest in the month of June. As of June 30th, there was short interest totaling 60,839 shares, a decline of 85.1% from the June 15th total of 409,683 shares. Currently, 1.0% of the company’s shares are short sold. Based on an average trading volume of 251,416 shares, the short-interest ratio is currently 0.2 days.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on FEED shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nanovibronix in a report on Friday, April 24th. Wall Street Zen upgraded Nanovibronix from a “strong sell” rating to a “sell” rating in a research note on Sunday. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has an average rating of “Sell”.

Insider Activity at Nanovibronix

In other news, insider Christian Michael Glibert sold 210,000 shares of the company’s stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $0.69, for a total value of $144,900.00. The sale was disclosed in a document filed with the SEC, which is available through this link. Corporate insiders own 5.20% of the company’s stock.

Nanovibronix Stock Performance

Shares of FEED traded down $0.07 during mid-day trading on Monday, hitting $0.46. 500,675 shares of the company’s stock were exchanged, compared to its average volume of 366,226. The company has a market capitalization of $2.79 million, a P/E ratio of -0.05 and a beta of 1.56. Nanovibronix has a fifty-two week low of $0.42 and a fifty-two week high of $17.40. The company has a 50-day moving average of $0.83.

Nanovibronix (NASDAQ:FEED) last posted its quarterly earnings data on Monday, May 18th. The company reported ($6.88) EPS for the quarter. Nanovibronix had a negative net margin of 923.20% and a negative return on equity of 54.25%. The business had revenue of $0.65 million during the quarter.

Nanovibronix Company Profile

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.